© 2021 MJH Life Sciences and HCPLive. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive. All rights reserved.
January 19, 2021
The VELYS Robotic-Assisted solution will be used in conjunction with the VELYS Digital Surgery Platform.
The researchers unexpectedly found sustained visual improvement in both eyes, despite only 1 eye being treated with AAV.
January 18, 2021
The randomized, blinded trial evaluated the safety and reactogenicity of aIIV3 and HD-IIV3 in adults 65 and older.
December 23, 2020
Fewer patients who received masitinib 4.5 mg/kg/day reached severe dementia stage.
December 18, 2020
Patients with any presence of small vessel disease had a 2-times greater risk of recurrent ischemic stroke than those without.
December 16, 2020
The agency is expected to rule on the Novartis treatment in 2021.
December 11, 2020
Researchers from USC propose a direct neurotoxic effect of particulate matter smaller than 2.5 μm.
December 08, 2020
After a sudden reversal and complex analyses, aducanumab’s future rests in the hands of the FDA while the community stands split on if the available data are enough to justify an approval.
November 23, 2020
Ongoing debates question whether or not lipid lowering in elderly patients offers similar clinical benefit as in younger patients.
November 18, 2020
Investigators find frailty is a key risk factor for age-related cognitive dysfunction and dementia.